Surrozen SRZN
NASDAQ SRZN
$22.76 +0.22 (+0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Surrozen (SRZN) Net Margin (2024 - 2026)

Surrozen (SRZN) posted quarterly Net Margin of 650.04% for Q1 2026, up 81029.0% year-over-year from N/an in Q1 2025, and up 62.08% quarter-over-quarter from 1714.2% in Q4 2025.

Analysis

Surrozen (SRZN) Net Margin (2024 - 2026) Analysis & Trends

Surrozen's Net Margin history runs 3 years deep, the most recent figure standing at 650.04% for Q1 2026.

  • In Q1 2026, Net Margin rose 81029.0% year-over-year to 650.04%; the TTM figure through Mar 2026 stood at 1219.48% (down 35034.0% YoY), while the FY2025 annual figure was 1493.64%, down 78279.0% from the prior year.
  • Net Margin for Q1 2026 stood at 650.04%, up from 1714.2% in the prior quarter.
  • The five-year high for Net Margin was 2218.51% in Q2 2025, with the low at 9175.73% in Q4 2024.
  • The 3-year median for Net Margin is 1460.33% (2025), against an average of 2583.47%.
  • Peak annual rise in Net Margin reached 746152 bps in 2025, while the deepest fall reached 727386 bps in 2025.
  • Surrozen's Net Margin stood at 9175.73% in 2024, then surged by 81 bps to 1714.2% in 2025, then soared by 62 bps to 650.04% in 2026.
  • Business Quant data shows SRZN's Net Margin at 650.04% in Q1 2026, 1714.2% in Q4 2025, and 7288.2% in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 30.23%
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 31.16%
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -539.31%
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.90%
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 12.74%
8 Royalty Pharma 28.45 Bn 27.61 Bn - 12.09%
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -3.12%
10 Surrozen 263.35 Mn 263.35 Mn - 640.76%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 640.76%
Mar 31, 2026 -190.88%
Dec 31, 2025 -2,244.51%
Sep 30, 2025 -7,288.20%
Jun 30, 2025 2,218.51%
Mar 31, 2025 -941.51%
Dec 31, 2024 -1,252.67%
Sep 30, 2024 -14.34%